Navigation Links
endpoint Launches PULSE 2.0 Allowing Clinical Research Teams to Save Additional Time and Money By Rapidly Deploying Studies With Custom Reporting
Date:10/19/2010

SAN FRANCISCO, Oct. 19 /PRNewswire/ -- endpoint Clinical (www.endpointclinical.com), a leader in Integrated Response Technology (IRT) development, today announced the release of PULSE 2.0™. endpoint PULSE is a proprietary platform that enables the configuration of fully validated, custom IRT systems for clinical trials in a fraction of the time required by traditional development. New in PULSE 2.0 is the ability for project managers to create and manage client-specific templates, ensuring that every study endpoint develops automatically contains the client's preferred configurations. PULSE 2.0 also offers enhanced reports and administrative functionality, with a focus on improved control over clinical supplies.

endpoint's PULSE configurable architecture meets Clinical Program Managers' demands for making mid-study changes quickly and easily. endpoint's PULSE platform combines IRT capabilities with pre-validated modules allowing clinical trials to move ahead at a more rapid rate due to project managers having access to the configurable design elements rather than relying on custom development for each change.

"Since launching PULSE in February, we've been compiling a long list of new features and functionality," said Jonathan Dole, co-founder and CEO, endpoint. "PULSE 2.0 is a blend of features our customers are asking for and new tools that enable us to deliver an even more robust IRT system in the same timeframe to which our customers are becoming accustomed."

About endpoint

endpoint is an innovative company dedicated to the development of the leading technology platforms for the life sciences industry. endpoint's founding team has been developing IRT systems for clinical trials since 1998 and have deployed systems to small, medium and large pharma for domestic and
'/>"/>

SOURCE endpoint
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
2. Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
3. TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints
4. LEO Pharmas PEP005 Meets Primary Endpoint in Phase III Trial for Pre-Cancerous Skin Condition
5. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
6. American Heart Association Late-Breaking Clinical Trial Report: New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint, but Did Reduce Death and Stent Thrombosis
7. Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies
8. Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients
9. Intercept Pharmaceuticals FXR Agonist INT-747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease
10. Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis
11. R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
(Date:6/29/2015)... 29, 2015 ReadSense, ... und Strand Life Sciences, weltweiter Marktführer in ... haben eine Kooperationsvereinbarung unterzeichnet. Laut Vereinbarung werden ... basierend auf NGS (Next-Generation Sequencing), für die ... von Epilepsie und primären Immundefizenz (PI)-Erkrankungen. Strand ...
(Date:6/29/2015)... and OXFORD, England ... Company (NYSE: LLY ) and Immunocore Limited ... immunotherapy-based clinical trial collaboration to explore the utility ... IMCgp100, in combination with Lilly,s galunisertib (LY2157299) and ... goal of the collaboration is to identify combination ...
Breaking Medicine Technology:Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4Das Genomic Center of Nanocenters 'Technospark' und 'Dubna', Russland und Strand Life Sciences, Indien werden gemeinsam Tests zur Diagnose von Erbkrankheiten entwickeln 2Das Genomic Center of Nanocenters 'Technospark' und 'Dubna', Russland und Strand Life Sciences, Indien werden gemeinsam Tests zur Diagnose von Erbkrankheiten entwickeln 3Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 2Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 3Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 4Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 5Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 6Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 7
... May 29, 2012  Horizon Pharma, Inc. (NASDAQ:  HZNP) ... Office has issued patent number 8,168,218 titled "Delayed ... RAYOS® (5 mg Delayed-Release Prednisone).  Horizon is the ... respect of the patent and SkyePharma,s related proprietary ...
... May 29, 2012  Reportlinker.com announces that ... available in its catalogue: ... Players, Markets and Forecasts   ... expectancy in the developed world increases ...
Cached Medicine Technology:Horizon Pharma Announces Issuance of U.S. Patent Covering RAYOS (delayed-release prednisone) 2Horizon Pharma Announces Issuance of U.S. Patent Covering RAYOS (delayed-release prednisone) 3Transdermal Hormone Replacement: Products, Players, Markets and Forecasts 2Transdermal Hormone Replacement: Products, Players, Markets and Forecasts 3
(Date:6/30/2015)... , ... June 30, 2015 , ... ... aspiring data scientists and analysts who are currently attending an accredited American educational ... of data has provided new insight into healthcare, the environment, political campaigns, and ...
(Date:6/30/2015)... ... June 30, 2015 , ... Americans report feeling more stressed than ever ... mornings, which puts stressed out people right over the edge. , Almost half ... sleep deprivation every night. Sleeping pills now lead the list of the most prescribed ...
(Date:6/30/2015)... ... , ... Scott Purdy, the spokesperson for Dephinitive Systems LLC, announces today that ... the XO stands for eXtra Operability (XO) which was chosen to reflect the company’s ... Cycle. , Provider XO, based in Cleveland OH, is part of the Cadrillion ...
(Date:6/30/2015)... ... June 30, 2015 , ... “It is never too early to be proactive ... particularly interested in getting the word out to children because sun damage is cumulative ... are extremely pleased with our new video which we feel is a fun way ...
(Date:6/29/2015)... ... 2015 , ... Sublime Beauty NATURALS® introduces its new USDA Certified Organic Sesame ... natural skincare and even culinary uses, was especially designed for Oil Pulling. , ... Oil Pulling can accomplish this. Oil Pulling is an Ayurvedic practice that is easy ...
Breaking Medicine News(10 mins):Health News:Izenda Offers Embedded BI and Analytics Scholarship 2Health News:Izenda Offers Embedded BI and Analytics Scholarship 3Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 3Health News:Dephinitive Systems Is Getting a New Name 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2
... patients at high risk of relapse, hematopoietic stem cell ... one of best options for treatment and a potential ... graft-versus-host disease (GVHD), a serious and often deadly post-transplant ... recognize the recipient,s own cells as foreign and react ...
... rules and meanings of your new home is especially challenging. ... journal of the Association for Psychological Science, finds that this ... after about the age of 15. Psychological scientists ... a critical windowif a developmental event doesn,t happen by a ...
... the release of two new provisional definitions of rheumatoid arthritis ... trials. According to research presented in the March ... RA who is enrolled in a clinical trial would need ... in remission: 1. Tender joint count, swollen joint ...
... News) -- Daily electronic records of symptoms can help ... a new study shows. Researchers gave 81 women ... patients used their PDA to report pain, sleep problems, ... for 30 days. The researchers at the University ...
... to "deactivate" migraine headaches produces lasting good results, with ... relief at five years, follow-up, reports a study in ... official medical journal of the American Society of Plastic ... migraine headaches were completely eliminated after surgery, according to ...
... that spring will come on time, and NASA satellite data ... are now anxious for the prediction to come true. ... last couple of days, including Phil,s home at Gobbler,s Knob ... rain this morning before it changed to snow as part ...
Cached Medicine News:Health News:Early infusion of donor T cells prevents graft versus host disease in blood cancer patients 2Health News:Early infusion of donor T cells prevents graft versus host disease in blood cancer patients 3Health News:Younger immigrants adjust to a new culture faster than do older immigrants 2Health News:Rheumatoid arthritis researchers redefine remission 2Health News:Rheumatoid arthritis researchers redefine remission 3Health News:Rheumatoid arthritis researchers redefine remission 4Health News:Migraine surgery offers good long-term outcomes 2Health News:GOES-13 Satellite sees Groundhog's Day on ice 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: